- Home
- BLFS
as 05-08-2025 4:00pm EST
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.2B | IPO Year: | 1989 |
| Target Price: | $30.57 | AVG Volume (30 days): | 567.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.15 - $29.55 | Next Earning Date: | 05-08-2025 |
| Revenue: | $82,254,000 | Revenue Growth: | 8.44% |
| Revenue Growth (this year): | 20.32% | Revenue Growth (next year): | 19.98% |
Stock Insider Trading Activity of BioLife Solutions Inc. (BLFS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Apr 9 '25 | Sell | $20.11 | 210 | $4,223.10 | 79,884 | |
| Berard Todd | BLFS | Chief Marketing Officer | Apr 9 '25 | Sell | $20.11 | 324 | $6,515.64 | 135,632 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Apr 9 '25 | Sell | $20.11 | 286 | $5,751.46 | 195,567 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Apr 9 '25 | Sell | $20.11 | 569 | $11,442.59 | 309,007 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Apr 9 '25 | Sell | $20.11 | 932 | $18,742.52 | 188,310 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Apr 1 '25 | Sell | $22.66 | 5,771 | $130,770.86 | 79,884 | |
| Berard Todd | BLFS | Chief Marketing Officer | Apr 1 '25 | Sell | $22.66 | 8,902 | $201,719.32 | 135,632 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Apr 1 '25 | Sell | $22.66 | 7,869 | $178,311.54 | 195,567 | |
| Mathew Aby J. | BLFS | EVP & Chief Scientific Officer | Apr 1 '25 | Sell | $22.66 | 10,589 | $239,946.74 | 309,007 | |
| Wichterman Troy | BLFS | Chief Financial Officer | Apr 1 '25 | Sell | $22.66 | 25,687 | $582,067.42 | 188,310 |
Latest BioLife Solutions Inc. News
BLFS Breaking Stock News: Dive into BLFS Ticker-Specific Updates for Smart Investing
GuruFocus.com
2 days ago
What To Expect From BioLife Solutions Inc (BLFS) Q1 2025 Earnings
Argus Research
3 days ago
BLFS: Lowering target price to $23.00
PR Newswire
9 days ago
BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
Argus Research
17 days ago
BLFS: Lowering target price to $23.00
Simply Wall St.
23 days ago
Shareholders have faith in loss-making BioLife Solutions (NASDAQ:BLFS) as stock climbs 8.7% in past week, taking five-year gain to 112%
Argus Research
24 days ago
BLFS: Raising target price to $24.00
Zacks
a month ago
Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?
Argus Research
a month ago
BLFS: Lowering target price to $22.00
Compare BLFS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.